Filing Details
- Accession Number:
- 0001209191-13-034931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-02 16:47:12
- Reporting Period:
- 2013-07-01
- Filing Date:
- 2013-07-02
- Accepted Time:
- 2013-07-02 16:47:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Pharmaceuticals Inc. | PCRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283535 | Gary Patou | C/O Mpm Asset Management 601 Gateway Blvd., Suite 350 South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-01 | 30,000 | $1.61 | 30,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-01 | 30,000 | $29.25 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-07-02 | 10,000 | $1.61 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-02 | 10,000 | $30.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-01 | 19,042 | $0.00 | 19,042 | $1.61 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-01 | 10,958 | $0.00 | 10,958 | $1.61 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-02 | 10,000 | $0.00 | 10,000 | $1.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-09-02 | No | 4 | M | Direct | |
| 48,084 | 2020-09-02 | No | 4 | M | Direct | |
| 38,084 | 2020-09-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 115 | Indirect | See Footnote |
Footnotes
- This transaction was pursuant to a 10b5-1 Plan.
- Represents weighted average sales price. The shares were sold at prices ranging from $28.79 to $29.63. The Reporting Person will provide upon request, to the SEC, the Issuer or securityholder of the Issuer, full information regarding the number of shares sold at each separate price.
- Shares held by Patou Family Trust, of which the reporting person is trustee.
- Fully vested.
- 25% of the option shares vest on September 2, 2011 and the remaining 75% of the option shares shall vest monthly over the next 36 months. The option shares become exercisable when vested.
Billionaire Hedge Funds
